XKRX
226320
Market cap141mUSD
Dec 05, Last price
11,800.00KRW
1D
-0.25%
1Q
-3.75%
Jan 2017
-72.56%
IPO
-84.00%
Name
It's Hanbul Co Ltd
Chart & Performance
P/E
12.59
P/S
1.46
EPS
937.33
Div Yield, %
—
Shrs. gr., 5y
—
Rev. gr., 5y
-6.97%
Revenues
142.43b
+2.35%
Net income
16.51b
+386.18%
CFO
23.45b
+26.33%
Dividend
Dec 27, 2023150 KRW/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
It'S Hanbul Co., Ltd. develops, manufactures, and sells cosmetics in South Korea and internationally. It offers skin care products, including toners, lotions, serums, gels/creams, emulsions, and effectors, as well as eye care, sun care, cleansings care, packs/masks, etc.; base makeups, such as BB/CC creams, concealers, high lighters, foundations, and powders; point makeups comprising eye care, lip care, eye shadow/brow, nail care, cheek/blushers, and high lighters; and body care products, which includes wash/scrubs, lotions/creams, perfumes, and mists/oils. The company also provides hair care and styling products; men and baby care products; hand/foot products; and brushes, puffs, and other beauty accessories products. The company was formerly known as It'S SKIN Co., Ltd. and changed its name to It'S Hanbul Co., Ltd. in 2017. It'S Hanbul Co., Ltd. was founded in 1989 and is headquartered in Seoul, South Korea.
Valuation
Title KRW in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | 2015‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||